Edition:
United States

Insider Trading: Interleukin Genetics Inc (ILIU.PK)

ILIU.PK on OTC Markets Group

0.12USD
27 Mar 2017
Change (% chg)

$0.01 (+4.53%)
Prev Close
$0.11
Open
$0.09
Day's High
$0.12
Day's Low
$0.09
Volume
10,200
Avg. Vol
24,226
52-wk High
$0.41
52-wk Low
$0.04

All Insider Trades
Trading Date Name Title Type Shares Traded Price
28 Jul 2016

Barrett (Michael James Ph.D.)

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

Baskett (Forest)

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

Sandell (Scott D)

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

Kolluri (Krishna Kittu)

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

BAY CITY CAPITAL L L C

Beneficial Owner of More than 10% Class Buy 29,616,700 $0.10
28 Jul 2016

Pyxis Innovations, Inc.

Beneficial Owner of More than 10% Class Buy 5,030,181 $0.10
28 Jul 2016

Weller (Harry R)

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

Barris (Peter J)

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

Weaver (James M)

Director Buy 100,603 $0.10
28 Jul 2016

Mott (David M)

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

Kerins Patrick J

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

Sonsini Peter W

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

DiPalma (Stephen J)

Chief Financial Officer Buy 100,603 $0.10
28 Jul 2016

Carbeau (Mark B)

Chief Executive Officer Buy 100,603 $0.10
28 Jul 2016

Growth Equity Opportunities Fund Iii L L C

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

BAY CITY CAPITAL L L C

Beneficial Owner of More than 10% Class Buy 564,386 $0.10
28 Jul 2016

Kornman (Kenneth S)

President Buy 25,150 $0.10
28 Jul 2016

Florence (Anthony A JR)

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10
28 Jul 2016

Viswanathan Ravi

Beneficial Owner of More than 10% Class Buy 20,120,724 $0.10

Institutional Holders

% Shares Owned: 65.93%
# of Holders: 4
Total Shares Held: 151,234,157
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0

Officers & Directors

Name Age Since Current Position

James Weaver

52 2014 Independent Chairman of the Board

Kenneth Kornman

69 2015 President, Chief Scientific Officer, Director

Mark Carbeau

56 2015 Chief Executive Officer, Director

Stephen DiPalma

57 2014 Interim Chief Financial Officer

Stephan Toutain

50 2016 Chief Commercial Officer

Lionel Carnot

49 2013 Independent Director

Joseph Landstra

39 2014 Independent Director

William Mills

60 2010 Independent Director

Dayton Misfeldt

42 2013 Independent Director

Adam Evertts

2016 IR Contact Officer